Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children (BEACON)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02308527 |
|
Recruitment Status :
Active, not recruiting
First Posted : December 4, 2014
Last Update Posted : February 15, 2022
|
Sponsor:
University of Birmingham
Collaborators:
Cancer Research UK
Roche Pharma AG
Imagine for Margo
EUSA Pharma, Inc.
Information provided by (Responsible Party):
University of Birmingham
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | August 1, 2021 |
| Estimated Study Completion Date : | December 2026 |